Skip to main content
Atrás
Watch Compare

Healthcare Triangle, Inc.

Calidad de datos: 100%
HCTI
Nasdaq Services Business Services
$2.40
▲ $0.04 (1.69%)
Cap. Mercado: 2.73 M
Precio
$2.36
Cap. Mercado
2.73 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Debt/Equity of 0.18 — conservative balance sheet
Negative free cash flow of -10.51 M
Capital efficient — spends only 0.08% of revenue on capex

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)-64.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-66.77%
Below sector avg (-15.95%)
ROIC-39.66%
Net Margin-48.84%
Op. Margin-45.16%

Seguridad

Debt / Equity
0.18
Below sector avg (0.39)
Current Ratio2.03
Interest Coverage-15.14

Valoración

PE (TTM)
-0.43
Above sector avg (-1.17)
P/B Ratio0.31
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Services (502 pares)
Métrica Acción Mediana del Sector
P/E -0.4 -1.2
P/B 0.3 1.4
ROE % -66.8 -16.0
Net Margin % -48.8 -19.4
Rev Growth 5Y % — 4.0
D/E 0.2 0.4

Precio Objetivo de Analistas

1 analista
Hold
Actual
$2.40
+12400.0%
Objetivo
$300.00
$300.00
$300.00
$300.00
Pronóstico
P/E Futuro -0.08
EPS Futuro -$31.80
Ingresos Est. 24.42 M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2026 -$31.80
-$31.80 – -$31.80
 24.42 M 1

Sorpresas de Ganancias

Últimos 2 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q32025 -$13.20 -$25.20 -90.9%
Q22025 N/A -$34.80 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -64.77% Revenue Growth (3Y) -49.51%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12.94 M Net Income (TTM) -6.32 M
ROE -66.77% ROA -44.50%
Gross Margin 8267.66% Operating Margin -45.16%
Net Margin -48.84% Free Cash Flow (TTM) -10.51 M
ROIC -39.66% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.18 Current Ratio 2.03
Interest Coverage -15.14 Asset Turnover 0.91
Working Capital 4.03 M Tangible Book Value 8.54 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.43 Forward P/E N/A
P/B Ratio 0.31 P/S Ratio 0.21
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -385.49%
Market Cap 2.73 M Enterprise Value 2.63 M
Per Share
EPS (Diluted TTM) -2.46 Revenue / Share 11.20
FCF / Share -9.10 OCF / Share -9.09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.08% FCF Conversion 166.29%
SBC-Adj. FCF -10.99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue 11.70 M 33.20 M 45.89 M 35.27 M
Net Income -5.97 M -12.34 M -9.61 M -5.95 M
EPS (Diluted) -1.13 -2.92 — -0.20
Gross Profit 1.07 B 1.07 B — —
Operating Income -4.75 M -11.35 M -10.42 M -5.36 M
EBITDA — — — —
R&D Expenses 429,000.0 799,000.0 5.95 M 5.26 M
SG&A Expenses — — 0.0 —
D&A 889,000.0 7.23 M 3.37 M 1.42 M
Interest Expense -1.21 M 968,000.0 212,000.0 566,735.0
Income Tax 12,000.0 35,000.0 63,000.0 24,246.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 1.96 M 10.05 M 20.76 M 24.61 M
Total Liabilities 7.08 M 9.51 M 8.38 M 8.48 M
Shareholders' Equity -5.11 M 538,000.0 12.48 M 16.13 M
Total Debt 2.65 M 3.43 M 2.41 M 2.21 M
Cash & Equivalents 20,000.0 1.23 M 1.34 M 1.77 M
Current Assets 1.45 M 5.73 M 7.75 M 11.80 M
Current Liabilities 7.08 M 8.12 M 6.15 M 6.25 M